Enhance your success in the business of biotech with BioWorld Today, the industry's most respected news source for more than 20 years. Delivering insider intelligence every business morning, you get the latest details on a wide range of issues dramatically affecting the industry. BioWorld Today includes coverage of: Therapeutic product development from early to late stage, strategic alliances, mergers and acquisitions, corporate financings both public and private, biotech company advancements and setbacks, scientific milestones, global regulatory updates, profiles of new and mature biotech and speciality pharmaceutical firms, big pharma's growing involvement in biotech, plus much more. Just take a look at what's covered in this week's issue:
GPCR Discoveries Honored with Chemistry Nobel Prize- Cancer Stem Cells: Just Hype or Hope for New Therapies?
- 'Gates' Swing Open to $30M in Genocea Series C Funding
- Report Raises Privacy Concerns on Whole Genome Sequencing
- 113th Congress to Focus on High-Tech Tax Reform
That's not all, with BioWorld Today you'll get the inside track on:
- What your competitors are doing ... so you can easily identify opportunities and threats.
- Where the smart money is going ... where top investors are placing their bets and who is raising funds.
- The latest technological innovations and discoveries ... to clinical study results across the industry.
- What the FDA and Congress are up to ... so you can prepare for coming changes and recent approvals.
With writers and editors stationed around the globe, BioWorld Today provides the critical news and insights you need to be competitive in this industry. Access your free issue now.
No comments:
Post a Comment